Celyad SA ADR Stock
Your prediction
Celyad SA ADR Stock
Our community identified positive and negative aspects for Celyad SA ADR stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Celyad SA ADR stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Celyad SA ADR in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Celyad SA ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Celyad SA ADR | - | - | - | - | - | - | - |
| Cardio3 Biosciences S.A. | 8.410% | 7.440% | -3.733% | -73.180% | -72.693% | -80.571% | -97.219% |
| Chromadex Corp | 0.910% | 0.000% | -9.756% | -7.500% | 7.767% | 273.989% | 20.130% |
| Intellia Therapeutics Inc | -4.250% | -6.699% | -6.061% | -40.633% | -32.354% | -79.776% | -82.519% |